Archive for the ‘Amira Pharmaceuticals’ Category

Amira Pharmaceuticals

July 27th, 2010 | Posted in Amira Pharmaceuticals

Amira Pharmaceuticals, San Diego, announced that it has hit two (2) clinical development milestones in its FLAP (5-lipoxygenase-activating protein) program with GlaxoSmithKline, triggering undisclosed amounts milestone payments, which enable Amira to continue to fund R&D opportunities.  Hari Kumar is Chief Business Officer. The milestones are related to the successful progression of the program to Phase […]